Antidepressant medications and other treatments of depressive disorders:: a CINP Task Force report based on a review of evidence

被引：50

作者：

Baghai, Thomas C. ^{[1
]}

Baldwin, David S. ^{[3
]}

Barrett, Barbara ^{[4
]}

Baumann, Pierre ^{[9
]}

Ghalib, Kareem ^{[10
,11
]}

Goodwin, Guy ^{[6
]}

Grunze, Heinz ^{[1
,2
]}

Knapp, Martin ^{[4
]}

Leonard, Brian E. ^{[7
]}

Markowitz, John C. ^{[10
,11
]}

Padberg, Frank ^{[1
]}

Pinder, Roger ^{[8
]}

Sartorius, Norman

Brand, Ursula ^{[5
]}

Fink, Max ^{[12
]}

Furukawa, Toshiaki A. ^{[13
]}

Fountoulakis, Konstantinos N. ^{[14
]}

Jensen, Peter ^{[10
,11
]}

Kanba, Shigenobu

Riecher-Roessler, Anita ^{[15
]}

机构：

[1] Univ Munich, Dept Psychiat & Psychotherapy, D-80336 Munich, Germany

[2] Newcastle Univ, Royal Victoria Infirm, Sch Neurol Neurobiol & Psychiat, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England

[3] Royal S Hants Hosp, Univ Dept Psychiat, Southampton SO14 0YG, Hants, England

[4] Univ London London Sch Econ & Polit Sci, London WC2A 2AE, England

[5] European Federat Assoc Families Mentally III Peop, D-78462 Constance, Germany

[6] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OC3 7JX, England

[7] Natl Univ Ireland, Galway, Ireland

[8] Pharma Consultant, Shertogenbosch, Netherlands

[9] Univ Dept Psychiat, CH-1008 Prilly, Switzerland

[10] Columbia Univ, New York Presbyterian Hosp, New York, NY 10021 USA

[11] Cornell Univ, New York Presbyterian Hosp, New York, NY 10021 USA

[12] SUNY Stony Brook, Sch Med, Dept Psychiat, New York, NY USA

[13] Nagoya City Univ, Grad Sch Med Sci, Dept Psychiat & Cognit Behav Med, Nagoya, Aichi 4678601, Japan

[14] Aristotle Univ Thessaloniki, Dept Psychiat 3, Thessaloniki, Greece

[15] Univ Basel Hosp, Psychiat Poliklin, CH-4031 Basel, Switzerland

来源：

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2007年 / 10卷

关键词：

D O I：

10.1017/S1461145707008255

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：S1 / S121

页数：121

共 161 条

[1]

Aarre T.F., Bugge P., ECT for patients taking lamotrigine, European Psychiatry, 17, SUPPL. 1, (2002)

[2]

Abrams R., Electroconvulsive Therapy, (2002)

[3]

Acharya N., Rosen A.S., Polzer J.P., D'Souza D.N., Perahia D.G., Cavazzoni P.A., Baldessarini R.J., Duloxetine: Meta-analyses of suicidal behaviors and ideation in clinical trials for major depressive disorder, Journal of Clinical Psychopharmacology, 26, pp. 587-594, (2006)

[4]

Ackerman D.L., Greenland S., Multivariate meta-analysis of controlled drug studies for obsessive-compulsive disorder, Journal of Clinical Psychopharmacology, 22, pp. 309-317, (2002)

[5]

Adli M., Baethge C., Heinz A., Langlitz N., Bauer M., Is dose escalation of antidepressants a rational strategy after a medium-dose treatment has failed? A systematic review, European Archives of Psychiatry and Clinical Neuroscience, 255, pp. 387-400, (2005)

[6]

Adli M., Berghofer A., Linden M., Helmchen H., Muller-Oerlinghausen B., Mackert A., Stamm T., Bauer M., Effectiveness and feasibility of a standardized stepwise drug treatment regimen algorithm for inpatients with depressive disorders: Results of a 2-year observational algorithm study, Journal of Clinical Psychiatry, 63, pp. 782-790, (2002)

[7]

Adli M., Rush A.J., Moller H.J., Bauer M., Algorithms for optimizing the treatment of depression: Making the right decision at the right time, Pharmacopsychiatry, 36, SUPPL. 3, (2003)

[8]

Depression Guideline Panel: Depression in Primary Care, (1993)

[9]

Evidence Report on Treatment of Depression: Newer Pharmacotherapies, (1999)

[10]

Aichhorn W., Whitworth A.B., Weiss U., Stuppaeck C., Mirtazapine and breast-feeding, American Journal of Psychiatry, 161, (2004)

← 1 2 3 4 5 6 7 8 9 10 →